Scribe Therapeutics cofounder and CEO Benjamin Oakes, PhD, joins a16z Bio + Health founding general partner Vijay Pande.
In this episode, Benjamin traces his journey from PhD student to pioneering CEO in genome editing. Benjamin discusses his early exposure to CRISPR technologies, his hands-on experience of transforming these bacterial immune systems into "genome editing scalpels," and the founding of Scribe. The conversation sheds light on the challenges of engineering these molecules, as well as the potential for life-changing therapeutics.
Journal Club: Remodeling Oncogenic Transcriptomes with Ben Cravatt and Gene Yeo
Health System Partnerships with Tommy Ibrahim
From the Archives: The Art & Science of Biology's Future with Jennifer Doudna
The Power of a Platform Company with Josh Mandel-Brehm
Culture and Company Building with Sam Corcos
Payments & Payors: Fintech's Role with Kurt Adams
American Optimism with Joe Lonsdale
Going to Market in Healthcare: B2C2B
Advancing the Field of Immunotherapeutics
Healthspan, Lifespan, and the Biology of Aging
Payors and Providers Post-Pandemic
Using AI to Take Bio Farther
Expert AI as a Healthcare Superpower
Cultivated Meat: Challenges, Opportunities, Future
AI is Here. Now What?
Regulatory Trends in Telehealth
Demystifying DC: Opportunities for Collaboration
The Consolidated Drug Channel and Cash-Pay Drugs
Bio x Games: Is a Fun, Therapeutic Game Possible?
Carolyn Bertozzi and Degrading Drugs for Problematic Proteins
Create your
podcast in
minutes
It is Free